LWA
Lineweaver Wealth Advisors’s AbbVie ABBV Stock Holding History
| Quarter | Market Value | Status | Shares |
Shares Change % | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $2.98M | Buy |
16,049
+1,093
| +7% | +$203K | 0.47% | 44 |
|
|
2025
Q1 | $3.14M | Sell |
14,956
-44
| -0.3% | -$9.22K | 0.53% | 40 |
|
|
2024
Q4 | $2.67M | Buy |
15,000
+2,626
| +21% | +$467K | 0.49% | 45 |
|
|
2024
Q3 | $2.44M | Buy |
12,374
+288
| +2% | +$56.9K | 0.47% | 43 |
|
|
2024
Q2 | $2.07M | Buy |
12,086
+10,065
| +498% | +$1.73M | 0.43% | 42 |
|
|
2024
Q1 | $368K | Buy |
2,021
+11
| +0.5% | +$2K | 0.09% | 107 |
|
|
2023
Q4 | $311K | Sell |
2,010
-474
| -19% | -$73.4K | 0.08% | 111 |
|
|
2023
Q3 | $371K | Buy |
2,484
+33
| +1% | +$4.92K | 0.11% | 108 |
|
|
2023
Q2 | $330K | Buy |
2,451
+113
| +5% | +$15.2K | 0.09% | 98 |
|
|
2023
Q1 | $373K | Buy |
2,338
+106
| +5% | +$16.9K | 0.11% | 96 |
|
|
2022
Q4 | $361K | Buy |
2,232
+18
| +0.8% | +$2.91K | 0.11% | 99 |
|
|
2022
Q3 | $297K | Buy |
2,214
+183
| +9% | +$24.5K | 0.1% | 106 |
|
|
2022
Q2 | $311K | Buy |
2,031
+568
| +39% | +$87K | 0.1% | 99 |
|
|
2022
Q1 | $237K | Buy |
+1,463
| New | +$237K | 0.07% | 128 |
|